Literature DB >> 33954894

Advanced CT techniques for assessing hepatocellular carcinoma.

Yuko Nakamura1, Toru Higaki2, Yukiko Honda2, Fuminari Tatsugami2, Chihiro Tani2, Wataru Fukumoto2, Keigo Narita2, Shota Kondo2, Motonori Akagi2, Kazuo Awai2.   

Abstract

Hepatocellular carcinoma (HCC) is the sixth-most common cancer in the world, and hepatic dynamic CT studies are routinely performed for its evaluation. Ongoing studies are examining advanced imaging techniques that may yield better findings than are obtained with conventional hepatic dynamic CT scanning. Dual-energy CT-, perfusion CT-, and artificial intelligence-based methods can be used for the precise characterization of liver tumors, the quantification of treatment responses, and for predicting the overall survival rate of patients. In this review, the advantages and disadvantages of conventional hepatic dynamic CT imaging are reviewed and the general principles of dual-energy- and perfusion CT, and the clinical applications and limitations of these technologies are discussed with respect to HCC. Finally, we address the utility of artificial intelligence-based methods for diagnosing HCC.

Entities:  

Keywords:  Artificial intelligence; Dual-energy CT; Hepatocellular carcinoma; Perfusion CT; Tomography, X-ray computed

Year:  2021        PMID: 33954894     DOI: 10.1007/s11547-021-01366-4

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  67 in total

1.  Comparison of MRI with liver-specific contrast agents and multidetector row CT for the detection of hepatocellular carcinoma: a meta-analysis of 15 direct comparative studies.

Authors:  Lihua Chen; Lin Zhang; Jing Bao; Jiuquan Zhang; Chuanming Li; Yunbao Xia; Xuequan Huang; Jian Wang
Journal:  Gut       Date:  2013-08-08       Impact factor: 23.059

2.  Is CT perfusion ready for liver cancer treatment evaluation?

Authors:  Eleni Liapi; Mahadevappa Mahesh; Dushyant V Sahani
Journal:  J Am Coll Radiol       Date:  2015-01       Impact factor: 5.532

3.  AASLD guidelines for the treatment of hepatocellular carcinoma.

Authors:  Julie K Heimbach; Laura M Kulik; Richard S Finn; Claude B Sirlin; Michael M Abecassis; Lewis R Roberts; Andrew X Zhu; M Hassan Murad; Jorge A Marrero
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

4.  New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.

Authors:  Christoph Wald; Mark W Russo; Julie K Heimbach; Hero K Hussain; Elizabeth A Pomfret; Jordi Bruix
Journal:  Radiology       Date:  2013-02       Impact factor: 11.105

Review 5.  Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Authors:  Norihide Yoneda; Osamu Matsui; Satoshi Kobayashi; Azusa Kitao; Kazuto Kozaka; Dai Inoue; Kotaro Yoshida; Tetsuya Minami; Wataru Koda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

6.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

Review 7.  Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis.

Authors:  Yoon Jin Lee; Jeong Min Lee; Ji Sung Lee; Hwa Young Lee; Bo Hyun Park; Young Hoon Kim; Joon Koo Han; Byung Ihn Choi
Journal:  Radiology       Date:  2015-01-05       Impact factor: 11.105

Review 8.  Updates on Imaging of Liver Tumors.

Authors:  Arya Haj-Mirzaian; Ana Kadivar; Ihab R Kamel; Atif Zaheer
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Blood Transfusions and Tumor Biopsy May Increase HCC Recurrence Rates after Liver Transplantation.

Authors:  Daniel Seehofer; Robert Öllinger; Timm Denecke; Moritz Schmelzle; Andreas Andreou; Eckart Schott; Johann Pratschke
Journal:  J Transplant       Date:  2017-01-05
View more
  16 in total

Review 1.  The Role of Catheter-Directed CT-Angiography in Radioembolisation.

Authors:  Kun Da Zhuang; Aaron Kian-Ti Tong; David Chee Eng Ng; Kiang Hiong Tay
Journal:  Cardiovasc Intervent Radiol       Date:  2022-05-20       Impact factor: 2.740

Review 2.  Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.

Authors:  Matteo Renzulli; Nicolò Brandi; Giulia Argalia; Stefano Brocchi; Andrea Farolfi; Stefano Fanti; Rita Golfieri
Journal:  Radiol Med       Date:  2022-01-13       Impact factor: 3.469

Review 3.  Management of cutaneous melanoma: radiologists challenging and risk assessment.

Authors:  Vincenza Granata; Igino Simonetti; Roberta Fusco; Sergio Venanzio Setola; Francesco Izzo; Luigi Scarpato; Vito Vanella; Lucia Festino; Ester Simeone; Paolo Antonio Ascierto; Antonella Petrillo
Journal:  Radiol Med       Date:  2022-07-14       Impact factor: 6.313

Review 4.  Radiomics in medical imaging: pitfalls and challenges in clinical management.

Authors:  Roberta Fusco; Vincenza Granata; Giulia Grazzini; Silvia Pradella; Alessandra Borgheresi; Alessandra Bruno; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Andrea Giovagnoni; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2022-03-28       Impact factor: 2.701

Review 5.  An introduction to photon-counting detector CT (PCD CT) for radiologists.

Authors:  Yuko Nakamura; Toru Higaki; Shota Kondo; Ikuo Kawashita; Isao Takahashi; Kazuo Awai
Journal:  Jpn J Radiol       Date:  2022-10-18       Impact factor: 2.701

Review 6.  Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect.

Authors:  Vincenza Granata; Roberta Fusco; Federica De Muzio; Carmen Cutolo; Sergio Venanzio Setola; Igino Simonetti; Federica Dell'Aversana; Francesca Grassi; Federico Bruno; Andrea Belli; Renato Patrone; Vincenzo Pilone; Antonella Petrillo; Francesco Izzo
Journal:  J Clin Med       Date:  2022-05-13       Impact factor: 4.964

7.  An update on radiomics techniques in primary liver cancers.

Authors:  Vincenza Granata; Roberta Fusco; Sergio Venazio Setola; Igino Simonetti; Diletta Cozzi; Giulia Grazzini; Francesca Grassi; Andrea Belli; Vittorio Miele; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2022-03-04       Impact factor: 2.965

8.  The Value of Color Doppler Ultrasound and CT Combined with Serum AFP Examination in the Diagnosis of Hepatocellular Carcinoma.

Authors:  Peiwan Jia; Yunjie Mao; Kahua Liu; XianJuan Wei
Journal:  J Healthc Eng       Date:  2022-03-26       Impact factor: 2.682

9.  Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma.

Authors:  Vincenza Granata; Roberta Fusco; Andrea Belli; Valentina Borzillo; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Alessandro Ottaiano; Guglielmo Nasti; Vincenzo Pilone; Antonella Petrillo; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2022-03-28       Impact factor: 2.965

10.  Dual-Energy Computed Tomography Imaging in Early-Stage Hepatocellular Carcinoma: A Preliminary Study.

Authors:  Jinping Li; Sheng Zhao; Zaisheng Ling; Daqing Li; Guangsheng Jia; Chenglei Zhao; Xue Lin; Yanmei Dai; Huijie Jiang; Song Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-01-04       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.